CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 161 enrolled
Drug / intervention
BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05953363
NCT05953363N/ACompleted
CompareCT.gov

Multi-center, Prospective, Open Label, Single Arm Post-market Study of BD NRFit™ Spinal Needles, NRFit™ Spinal Introducer Needles, and NRFit™ Syringes on Participants Who Are Receiving Neuraxial Procedure.

Becton, Dickinson and Company·observational·Posted Jul 20, 2023·Updated Dec 19, 2025

In Brief

An observational study evaluating BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes for Anesthesia and Analgesia. Completed, enrolled 161 participants across 5 sites in 3 countries.

Detailed Summary

Multi-center, prospective, open label, single arm post-market study to assess the real-world safety and efficacy of BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes used in an on-market fashion.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia, Analgesia
CountriesAustria, Germany, Spain
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJul 20, 2023
Enrollment StartJul 24, 2023
Primary CompletionMay 28, 2024
Study CompletionJun 7, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.9 years ago

Interventions

BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringesdevice

Insertion of a BD NRFit™ spinal needle and optional BD NRFit™ Spinal Introducer Needle using a BD NRFit™ Syringe to perform the neuraxial procedure.